Randomized Phase 2 Trial Evaluating the Addition of the IGF-lR Monoclonal Antibody Ganitumab (AMG479, NSC#750008, IND#120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
General Information
Age Group
Status
Active
Protocol Number
AEWS1221
Offered At
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
